LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 211 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $544,705 | -11.7% | 12,300 | +11.8% | 0.00% | 0.0% |
Q1 2024 | $616,880 | -6.1% | 11,000 | +0.9% | 0.00% | -25.0% |
Q4 2023 | $657,270 | +127031.5% | 10,900 | +41.6% | 0.00% | +33.3% |
Q3 2023 | $517 | -2.8% | 7,700 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $532 | +43.0% | 7,700 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $372 | -3.1% | 7,700 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $384 | – | 7,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 372,989 | $10,824,000 | 8.53% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $47,279,000 | 6.12% |
Vivo Capital, LLC | 2,755,007 | $79,950,000 | 2.81% |
Consonance Capital Management LP | 896,608 | $26,020,000 | 2.77% |
Yong Rong (HK) Asset Management Ltd | 198,312 | $5,756,000 | 1.58% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,054,242 | $30,594,000 | 1.28% |
Hudson Bay Capital Management LP | 2,167,274 | $62,894,000 | 0.78% |
Capital International, Inc./CA/ | 1,916,845 | $55,627,000 | 0.52% |
Capital International Sarl | 172,546 | $5,007,000 | 0.48% |
Novo Holdings A/S | 254,176 | $7,376,000 | 0.30% |